We are live on ! Find out more
DMK

David M. Knott Portfolio holdings

AUM $275M
1-Year Est. Return 59.23%
This Fund
S&P 500
This Quarter Est. Return
+15.74%
1 Year Est. Return
+59.23%
3 Year Est. Return
+80.95%
5 Year Est. Return
+223.18%
10 Year Est. Return
AUM
$308M
AUM Growth
+$41.5M
Cap. Flow
+$7.42M
Cap. Flow %
2.41%
Top 10 Hldgs %
61.93%
Holding
115
New
6
Increased
17
Reduced
6
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 48.45%
2 Technology 14.62%
3 Energy 8.34%
4 Industrials 6.41%
5 Financials 5.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LKQ icon
26
LKQ Corp
LKQ
$6.46B
$2.38M 0.77%
75,000
XENE icon
27
Xenon Pharmaceuticals
XENE
$5.81B
$2.29M 0.74%
173,390
CPRX
28
DELISTED
Catalyst Pharmaceutical
CPRX
$2.09M 0.68%
553,475
+40,000
+8% +$125K
CHCT
29
Community Healthcare Trust
CHCT
$428M
$1.86M 0.6%
60,000
CXW icon
30
CoreCivic
CXW
$3.34B
$1.82M 0.59%
75,000
STML
31
DELISTED
Stemline Therapeutics, Inc.
STML
$1.75M 0.57%
105,287
+15,287
+17% +$245K
ARNA
32
DELISTED
Arena Pharmaceuticals Inc
ARNA
$1.73M 0.56%
37,491
+2,800
+8% +$114K
INDP icon
33
Indaptus Therapeutics
INDP
$152M
$1.6M 0.52%
+127
New +$1.21M
AB icon
34
AllianceBernstein
AB
$3.43B
$1.54M 0.5%
50,500
HZNP
35
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$1.44M 0.47%
73,640
ZGNX
36
DELISTED
Zogenix, Inc.
ZGNX
$1.29M 0.42%
26,039
+4,039
+18% +$206K
QTNT
37
DELISTED
Quotient Limited Ordinary Shares
QTNT
$1.26M 0.41%
4,175
EIGR
38
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.21M 0.39%
3,356
+297
+10% +$102K
AIMT
39
DELISTED
Aimmune Therapeutics
AIMT
$1.2M 0.39%
44,152
+3,372
+8% +$95.4K
RHP icon
40
Ryman Hospitality Properties
RHP
$8.92B
$1.07M 0.35%
12,400
CNQ icon
41
Canadian Natural Resources
CNQ
$101B
$1.06M 0.34%
66,059
BDSI
42
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$1.05M 0.34%
374,000
+166,000
+80% +$466K
JNJ icon
43
Johnson & Johnson
JNJ
$646B
$1.01M 0.33%
7,280
CNCE
44
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$979K 0.32%
66,000
+14,443
+28% +$227K
VZ icon
45
Verizon
VZ
$208B
$977K 0.32%
18,311
XLRN
46
DELISTED
Acceleron Pharma
XLRN
$939K 0.3%
16,400
XRN.PRA
47
Chiron Real Estate Inc Series A Preferred Stock
XRN.PRA
$78.1M
$879K 0.29%
35,000
T icon
48
AT&T
T
$178B
$741K 0.24%
29,194
SVC
49
Service Properties Trust
SVC
$1.02B
$721K 0.23%
5,000
CBAY
50
DELISTED
Cymabay Therapeutics
CBAY
$698K 0.23%
63,000
+43,000
+215% +$534K

Similar funds

David M. Knott's Q3 2018 Portfolio in Review

As of Q3 2018, David M. Knott held 115 positions worth $308M, up 16% from $267M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

David M. Knott's Q3 2018 filing shows 6 new, 17 increased, 6 reduced and 10 closed positions. Its largest new stake was FTAI Aviation: 586,746 shares worth $9.11M. The largest sale was Octave Specialty Group, an estimated $2.89M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, up from 44% a quarter earlier, followed by Technology and Energy.

  • David M. Knott's largest Q3 2018 buy was FTAI Aviation: 586,746 shares worth $9.11M.
  • David M. Knott added most to MPLX in Q3 2018, an estimated $4.48M increase.
  • David M. Knott's biggest Q3 2018 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $293K.
  • David M. Knott fully exited Octave Specialty Group in Q3 2018, selling an estimated $2.89M.
  • David M. Knott's ten largest holdings make up 62% of its $308M portfolio in Q3 2018.
  • David M. Knott opened 6 new positions and closed 10 in Q3 2018.
  • David M. Knott's portfolio value rose 16% quarter-over-quarter to $308M.

Based on David M. Knott's 13F filing for Q3 2018, filed 13 Nov 2018.